Drugs / Disodium Ascorbyl Phytostanol Phosphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00293878 | Nov 2005 → ? | hyperlipoproteinemia | Forbes Medi-Tech | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Disodium Ascorbyl Phytostanol Phosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00293878 ↗ |
| Known as | FM-VP4 | “Disodium Ascorbyl Phytostanol Phosphate (FM-VP4)” NCT00293878 ↗ |